Hes intelligent, resourceful, understanding, fun and explains everything in detail
These findings offer hope to those who havent responded well to traditional treatment options or who experience intense cravings and impulsivity
Phase 1: Weeks 13 (Disc Repair Priority) BPC-157: 500mcg/day subQ TB-500: 2.5mg/week subQ GHK-Cu: 1mg/day subQ Focus: disc tissue repair, nerve decompression, anti-inflammation Activity: physical therapy, gentle mobility, no loading Phase 2: Weeks 48 (Add Recomp Layer) Continue Phase 1 stack Add CJC-1295 no DAC + Ipamorelin: 100mcg each, pre-bed This layer drives GH pulsatility for tissue remodeling and begins the body recomposition phase Activity: begin light lifting as cleared by PT Phase 3: Weeks 9+ (Maintenance and Fat Loss) TB-500: Drop to maintenance 1.25mg/week BPC-157: Can drop to 250mcg/day or 5 days/week CJC+Ipa: Continue pre-bed Optional add: Tesamorelin (12mg/day, 5 days/week) for visceral fat and GH optimization pairs well with CJC+Ipa Optional add: Retatrutide for more aggressive fat loss if that's a priority What to Expect: Recovery Timeline Weeks 12: Reduced acute nerve pain is often the first noticeable change
Ingredients N-Acetyl L-Cysteine: 500mg per serving Pharmaceutical-grade amino acid derivative Superior bioavailability compared to standard L-cysteine The acetyl group attached to the cysteine molecule protects it from degradation in the digestive tract, allowing for enhanced absorption and tissue uptake
However, this MDL will solely be for people who took a GLP-1 (like Mounjaro) and developed a rare eye stroke called non-arteritic anterior ischemic optic neuropathy (NAION)
